February 11, 2025

Oramed (ORMP) Stock Skyrockets Amid Joint Venture Development Plans

After Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) announced a strategic joint venture for the development and commercialization of its oral medication delivery technology, the company’s shares shot up the charts today. At $2.84 as of the most recent trading session, ORMP shares had risen 30.65%. OraTech Pharmaceuticals’ establishment A new company called OraTech Pharmaceuticals Inc. was …

Oramed (ORMP) Stock Skyrockets Amid Joint Venture Development Plans Read More »

PLTR Stock on the Rise: Here’s Why Palantir Shares Are Gaining Momentum!

The Unexpected Surge: What’s Going On with Palantir? In the ever-volatile world of tech stocks, Palantir Technologies (PLTR) has managed to surprise even the most seasoned investors. After months of flying under the radar, PLTR has suddenly emerged as one of the hottest stocks on Wall Street. Its recent rally isn’t just a blip—the stock …

PLTR Stock on the Rise: Here’s Why Palantir Shares Are Gaining Momentum! Read More »

Anterix (ATEX) Stock Rises Amid Strategic Growth Plans

The price of Anterix Inc. (NASDAQ: ATEX) shares increased significantly today, rising 26.26% to $36.01 according to the most recent market report. The rise comes after news of a strategic review process emerged, aiming to capitalize on the utility industry’s increasing demand in the private cellular broadband sector. Engaging Financial Experts for Strategic assessment In …

Anterix (ATEX) Stock Rises Amid Strategic Growth Plans Read More »

Travere (TVTX) Sees Stock Uptick Amid FDA Approval Advancements

Following the news of regulatory success, Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are significantly increasing on the charts today. TVTX stock was trading at $24.06 as of the last check, rising 14.03%. The surge is driven by the news of regulatory process discussion for its medication candidate FILSPARI with the U.S. Food and medication Administration …

Travere (TVTX) Sees Stock Uptick Amid FDA Approval Advancements Read More »

Why Firefly Neuroscience (AIFF) Stock Is Gaining Momentum Today?

Firefly Neuroscience, Inc. (NASDAQ: AIFF) shares are showing a remarkable surge following its acceptance into the prestigious NVIDIA Connect program. AIFF’s stock was up 63.23% at $5.06 as of the latest check. For the company that specializes in artificial intelligence (AI) solutions meant to improve brain health outcomes for people with neurological and mental problems, …

Why Firefly Neuroscience (AIFF) Stock Is Gaining Momentum Today? Read More »

Lipella Pharmaceuticals (LIPO) Stock Soars In Pre-Hour Session

Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares are on a significant surge following the announcement of topline data from a critical clinical study. As of the most recent premarket check today, LIPO stock was up 49.84% on the charts, reaching $4.57. Promising Results from LP-310 Trial Lipella Pharmaceuticals (LIPO) announced topline data from Phase 2a multicenter …

Lipella Pharmaceuticals (LIPO) Stock Soars In Pre-Hour Session Read More »

SelectQuote (SLQT) Sees Pre-Market Boost After Impressive Financials

After releasing its fiscal year 2025 second-quarter financial results, SelectQuote, Inc. (NYSE: SLQT) saw a significant increase in the value of its shares. The shares of SLQT increased 26.48% during premarket trading, hitting $5.54. Investor confidence in the company’s strong financial performance and strategic expansion ambitions is reflected in this spike. Outstanding Financial Results  Consolidated …

SelectQuote (SLQT) Sees Pre-Market Boost After Impressive Financials Read More »

Lifeward (LFWD) Shares Continue Momentum In Pre-Hour Surge

Lifeward Ltd. (NASDAQ: LFWD) is extending its upward momentum in today’s trading session, continuing a sharp rally from the previous day. After a strong 33.57% increase the previous session, when it ended at $1.87, LFWD stock has risen 10.64% to $2.07 as of the most recent premarket check. The company’s recent historic deal with one …

Lifeward (LFWD) Shares Continue Momentum In Pre-Hour Surge Read More »